Tokyo, Japan

Tatsuo Haneishi


Average Co-Inventor Count = 5.4

ph-index = 4

Forward Citations = 42(Granted Patents)


Location History:

  • Hiromachi, JP (1980 - 1991)
  • Tokyo, JP (1982 - 1993)

Company Filing History:


Years Active: 1980-1993

Loading Chart...
15 patents (USPTO):Explore Patents

Title: The Innovative Journey of Tatsuo Haneishi: A Pioneer in Antibiotic Production

Introduction: Tatsuo Haneishi is a prominent inventor based in Tokyo, Japan, known for his groundbreaking contributions to the field of microbiology and antibiotic production. With 15 patents to his name, Haneishi has made significant strides in developing fermentation processes that have the potential to enhance the efficacy of antibiotics.

Latest Patents: Haneishi's most recent inventions include a fermentation process for preparing antibiotics known as mureidomycins A, B, and C. He has innovated a process for producing mureidomycins A, B, C, or D by cultivating the microorganism Streptomyces flavidovirens SANK 60486 in a specialized culture medium. This process allows for the isolation of mureidomycins from the cultured broth, showcasing Haneishi's contribution to pharmaceutical advancements. Additionally, he has developed a process for producing an imidazoledione compound, referred to as Substance No. 51262, created by cultivating a suitable microorganism of the genus Streptomyces, particularly the new strain SANK 63584. This compound exhibits herbicidal and growth retardant properties, opening new avenues in agricultural biotech.

Career Highlights: Haneishi's career is marked by his dedication to research and innovation at Sankyo Company, Limited, where he continues to focus on the development of novel pharmaceutical solutions. His extensive research has not only garnered numerous patents but has also positioned him as a respected figure in the scientific community, particularly in the realms of antibiotic formulations and biotechnological applications.

Collaborations: Throughout his career, Haneishi has collaborated with esteemed colleagues, including Mutsuo Nakajima and Akio Torikata. These partnerships have been instrumental in advancing their shared vision of enhancing antibiotic production processes and developing new compounds with diverse applications.

Conclusion: Tatsuo Haneishi's contributions to the field of microbiology and antibiotic production underscore the importance of innovation in addressing global health challenges. His patents and ongoing research signify a promising future for antibiotic development, providing hope for more effective treatments in the fight against bacterial infections. Through his work at Sankyo Company, Limited, Haneishi exemplifies the role of inventors in shaping the landscape of modern medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…